Table 3 Baseline characteristics according to different trajectories of platelets
Characteristics | Group 1(N = 27) | Group 2(N = 42) | Group 3(N = 60) | Group 4(N = 20) | P |
|---|---|---|---|---|---|
The number of deaths, n | 15 | 15 | 8 | 5 | |
Mortality rate per 1000 person-days | 1.90 | 0.58 | 0.47 | 0.70 | 0.004 |
Follow-up times, (days) | 99.00 (43.00, 289.50) | 355.50 (182.25, 814.00) | 327.50 (156.75, 1055.00) | 185.50 (129.75, 464.25) | 0.002 |
Age, year | 54.00 (45.50, 64.00) | 53.00 (43.00, 60.00) | 47.50 (34.00, 57.75) | 52.00 (43.25, 65.00) | 0.209 |
Female, n (%) | 14 (51.85) | 19 (45.24) | 33 (55.00) | 8 (40.00) | 0.612 |
WBC counts, 109/L | 7.07 (1.50, 43.52) | 17.05 (6.59, 46.22) | 13.77 (6.78, 54.94) | 3.57 (2.09, 16.16) | 0.083 |
HB, g/L | 69.11 ± 19.11 | 71.52 ± 20.27 | 86.67 ± 23.88 | 82.30 ± 26.81 | < 0.001 |
Bone Marrow Blasts(%) | 0.60 (0.38, 0.79) | 0.57 (0.37, 0.87) | 0.60 (0.42, 0.80) | 0.47 (0.40, 0.75) | 0.877 |
Missing sample | 0 | 1 | 9 | 2 | |
PLT, 109/L | 34.00 (17.50, 56.50) | 20.50 (10.25, 36.25) | 41.00 (20.75, 74.25) | 149.00 (120.00, 232.00) | < 0.001 |
CR1, n(%) | 0 (0) | 30 (71.43) | 50 (83.33) | 5 (25.00) | < 0.001 |